Hims & Hers Health：诺和诺德的诉讼是一种“公然的攻击”_老虎社区_美港股上老虎

Hims & Hers Health：诺和诺德的诉讼是一种“公然的攻击”

老虎资讯综合02-09 21:54

周一，Hims & Hers Health Inc. 发表声明：诺和诺德的诉讼是对数百万依赖复方药获得个性化治疗的美国民众公然的攻击，大型制药企业再次将美国司法体系武器化以限制消费者选择。

声明称，Hims & Hers Health长期为数百万美国人提供安全获取个性化医疗服务的渠道，将继续奋战以保障选择权、可负担性及可及性。

诺和诺德当天早些时候宣布，已就Hims & Hers Health在美国市场销售的复方司美格鲁肽产品侵犯专利提起诉讼。

截至发稿，Hims & Hers Health的盘前跌幅扩大至超22%。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

函盖乾坤截断众流随波逐浪
·08:49
那么你到底有没有侵犯专利呢？
回复
点赞
举报

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1168115277?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/93eef2d936f05d4726617f16ec785955","is_english":false,"pubTime":"2026-02-09 21:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1168115277","market":"us","top_or_hot":-1,"title":"Hims & Hers Health：诺和诺德的诉讼是一种“公然的攻击”","media":"老虎资讯综合","content":"<html><head></head><body><p>周一，<a href=\"https://laohu8.com/S/HIMS\">Hims &amp; Hers Health Inc.</a> 发表声明： <a href=\"https://laohu8.com/S/NVO\">诺和诺德</a> 的诉讼是对数百万依赖复方药获得个性化治疗的美国民众公然的攻击，大型制药企业再次将美国司法体系武器化以限制消费者选择。</p><p>声明称，Hims &amp; Hers Health长期为数百万美国人提供安全获取个性化医疗服务的渠道，将继续奋战以保障选择权、可负担性及可及性。</p><p>诺和诺德当天早些时候宣布，已就Hims &amp; Hers Health在美国市场销售的复方司美格鲁肽产品侵犯专利提起诉讼。</p><p>截至发稿，Hims &amp; Hers Health的盘前跌幅扩大至超22%。</p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1d2ef067a4fc93d89080158e0154607b\" tg-width=\"1161\" tg-height=\"417\"/></p><p></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hims & Hers Health：诺和诺德的诉讼是一种“公然的攻击”</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHims & Hers Health：诺和诺德的诉讼是一种“公然的攻击”\n</h2>\n\n<h4 class=\"meta\">\n\n2026-02-09 21:54 北京时间&nbsp;&nbsp;&nbsp;<strong>老虎资讯综合</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>周一，Hims & Hers Health Inc. 发表声明： 诺和诺德 的诉讼是对数百万依赖复方药获得个性化治疗的美国民众公然的攻击，大型制药企业再次将美国司法体系武器化以限制消费者选择。声明称，Hims & Hers Health长期为数百万美国人提供安全获取个性化医疗服务的渠道，将继续奋战以保障选择权、可负担性及可及性。诺和诺德当天早些时候宣布，已就Hims & Hers Health在...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"","article_id":"1168115277","we_media_id":"102","thumbnails":["https://static.tigerbbs.com/93eef2d936f05d4726617f16ec785955"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1168115277","pubTimestamp":1770645283,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"老虎资讯综合","introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"将继续奋战以保障选择权、可负担性及可及性。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{},"translate_title":"Hims & Hers Health: Novo Nordisk's lawsuit is a'blatant attack '","themeId":"961f70a84cc7ef0c9ed061f364f6809e","isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/05b50cd6815471913b42a5e11bf6d71b","symbols_score_info":{"HIMZ":1,"HIMY":1,"HIMS":2,"HMYY":1,"NVO":2},"content_text":"周一，Hims & Hers Health Inc. 发表声明： 诺和诺德 的诉讼是对数百万依赖复方药获得个性化治疗的美国民众公然的攻击，大型制药企业再次将美国司法体系武器化以限制消费者选择。声明称，Hims & Hers Health长期为数百万美国人提供安全获取个性化医疗服务的渠道，将继续奋战以保障选择权、可负担性及可及性。诺和诺德当天早些时候宣布，已就Hims & Hers Health在美国市场销售的复方司美格鲁肽产品侵犯专利提起诉讼。截至发稿，Hims & Hers Health的盘前跌幅扩大至超22%。","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[{"id":531247781671040,"gmtCreate":1770684568798,"gmtModify":1770684570948,"author":{"id":"3544441872957647","authorId":"3544441872957647","name":"函盖乾坤截断众流随波逐浪","avatar":"https://static.tigerbbs.com/f4602544b3ccc4c41a2be942e28cbf75","vip":1,"crmLevel":8,"crmLevelSwitch":1,"idStr":"3544441872957647","authorIdStr":"3544441872957647"},"htmlText":"那么你到底有没有侵犯专利呢？","listText":"那么你到底有没有侵犯专利呢？","text":"那么你到底有没有侵犯专利呢？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/531247781671040","repostId":1168115277,"repostType":2,"repost":{"id":"1168115277","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1770645283,"share":"https://www.laohu8.com/m/news/1168115277?lang=zh_CN&edition=full","pubTime":"2026-02-09 21:54","market":"us","language":"zh","title":"Hims & Hers Health：诺和诺德的诉讼是一种“公然的攻击”","url":"https://stock-news.laohu8.com/highlight/detail?id=1168115277","media":"老虎资讯综合","summary":"将继续奋战以保障选择权、可负担性及可及性。","content":"<html><head></head><body><p>周一，<a href=\"https://laohu8.com/S/HIMS\">Hims &amp; Hers Health Inc.</a> 发表声明： <a href=\"https://laohu8.com/S/NVO\">诺和诺德</a> 的诉讼是对数百万依赖复方药获得个性化治疗的美国民众公然的攻击，大型制药企业再次将美国司法体系武器化以限制消费者选择。</p><p>声明称，Hims &amp; Hers Health长期为数百万美国人提供安全获取个性化医疗服务的渠道，将继续奋战以保障选择权、可负担性及可及性。</p><p>诺和诺德当天早些时候宣布，已就Hims &amp; Hers Health在美国市场销售的复方司美格鲁肽产品侵犯专利提起诉讼。</p><p>截至发稿，Hims &amp; Hers Health的盘前跌幅扩大至超22%。</p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1d2ef067a4fc93d89080158e0154607b\" tg-width=\"1161\" tg-height=\"417\"/></p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hims & Hers Health：诺和诺德的诉讼是一种“公然的攻击”</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHims & Hers Health：诺和诺德的诉讼是一种“公然的攻击”\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2026-02-09 21:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>周一，<a href=\"https://laohu8.com/S/HIMS\">Hims &amp; Hers Health Inc.</a> 发表声明： <a href=\"https://laohu8.com/S/NVO\">诺和诺德</a> 的诉讼是对数百万依赖复方药获得个性化治疗的美国民众公然的攻击，大型制药企业再次将美国司法体系武器化以限制消费者选择。</p><p>声明称，Hims &amp; Hers Health长期为数百万美国人提供安全获取个性化医疗服务的渠道，将继续奋战以保障选择权、可负担性及可及性。</p><p>诺和诺德当天早些时候宣布，已就Hims &amp; Hers Health在美国市场销售的复方司美格鲁肽产品侵犯专利提起诉讼。</p><p>截至发稿，Hims &amp; Hers Health的盘前跌幅扩大至超22%。</p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1d2ef067a4fc93d89080158e0154607b\" tg-width=\"1161\" tg-height=\"417\"/></p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/93eef2d936f05d4726617f16ec785955","relate_stocks":{},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168115277","content_text":"周一，Hims & Hers Health Inc. 发表声明： 诺和诺德 的诉讼是对数百万依赖复方药获得个性化治疗的美国民众公然的攻击，大型制药企业再次将美国司法体系武器化以限制消费者选择。声明称，Hims & Hers Health长期为数百万美国人提供安全获取个性化医疗服务的渠道，将继续奋战以保障选择权、可负担性及可及性。诺和诺德当天早些时候宣布，已就Hims & Hers Health在美国市场销售的复方司美格鲁肽产品侵犯专利提起诉讼。截至发稿，Hims & Hers Health的盘前跌幅扩大至超22%。","news_type":1,"symbols_score_info":{"HIMZ":1,"HIMY":1,"HIMS":2,"HMYY":1,"NVO":2}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":1,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}